PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Cholestifin LLC

Press Release

Share      Blog

Receive press releases from Cholestifin LLC: By Email PDF Version RSS Feeds:

US Based Company Produced Cholestifin Drops for Normalizing Cholesterol Levels


Cholestifin is a liquid for oral use, intended to normalize cholesterol levels.

US Based Company Produced Cholestifin Drops for Normalizing Cholesterol Levels
Uniondale, NY, September 04, 2017 --(PR.com)-- American company manufactured Cholestifin, that is intended to normalize cholesterol levels in human's body. The supplement is produced in liquid form, and is sold in 50 ml bottle. The product is already available online and will be sold at a lower price the first couple of days.

Beta-glucan, Hawthorn, Omega - 3 and L-carnitine are the active ingredients in Cholestifin's formula. Beta-glucan is widely used in medicine. It is usually prescribed to patients, suffering from high cholesterol, diabetes etc. When given by injection, beta-glucan might stimulate the immune system. Omega 3 fats have numerous of health benefits. The most common medical conditions that consuming more omega-3 foods have been prescribed for include high cholesterol, depression, anxiety, inflammation, arthritis, diabetes. L-carnitine is an amino acid derivative that is produced in the body, but it is also available as a supplement. It is used for conditions of the heart and blood vessels including heart-related chest pain, heart attack, leg pain caused by circulation problems, and high cholesterol. Hawthorn is a plant, usually used to promote the health of the circulatory system, treat high blood pressure, and cardiac arrhythmia. It is also applied in patients with high levels of harmful cholesterol.

CDC (Centers for Disease Control - https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_cholesterol.htm) announces that 71 million American adults (33.5%) have high low-density lipoprotein (LDL), or bad cholesterol. This condition could be quite dangerous, so it should be treated in any case. Treatment include medicines, prescribed by а physician, changes in lifestyle and diet, and оptimal physical activity.
Contact Information
Cholestifin LLC
Mariah Evans
203-807-0768
Contact
www.cholestifin.com

Click here to view the list of recent Press Releases from Cholestifin LLC
Promote Your Business